Last Updated : Jan 22, 2019 02:49 PM IST | Source: Moneycontrol.com

Alembic Pharma Consolidated December 2018 Net Sales at Rs 1,018.15 crore, Up 21.21% Y-o-Y.

live

bselive
nselive

Volume

Todays L/H

More

Reported Consolidated quarterly numbers for Alembic Pharmaceuticals are:

Net Sales at Rs 1,018.15 crore in December 2018 Up 21.21% from Rs. 840.02 crore in December 2017.

Quarterly Net Profit at Rs. 169.83 crore in December 2018 Up 30.04% from Rs. 130.60 crore in December 2017.

EBITDA stands at Rs. 245.75 crore in December 2018 Up 30.82% from Rs. 187.85 crore in December 2017.

Alembic Pharma EPS has Increased to Rs. 9.01 in December 2018 from Rs. 6.93 in December 2017.

Alembic Pharma shares closed at 590.65 on January 21, 2019 (NSE) and has given 8.24% returns over the last 6 months and 7.34% over the last 12 months.

Alembic Pharmaceuticals
Consolidated Quarterly Results	in Rs. Cr.

	Dec'18	Sep'18	Dec'17
Net Sales/Income from operations	1,018.15	1,127.06	840.02
Other Operating Income	--	--	--
Total Income From Operations	1,018.15	1,127.06	840.02
EXPENDITURE
Consumption of Raw Materials	201.72	239.83	218.96
Purchase of Traded Goods	46.16	64.59	75.35
Increase/Decrease in Stocks	0.58	-32.37	-67.87
Power & Fuel	--	--	--
Employees Cost	198.40	182.62	147.43
Depreciation	29.05	28.63	26.40
Excise Duty	--	--	--
Admin. And Selling Expenses	--	--	--
R & D Expenses	--	--	--
Provisions And Contingencies	--	--	--
Exp. Capitalised	--	--	--
Other Expenses	329.06	370.05	278.62
P/L Before Other Inc., Int., Excpt. Items & Tax	213.18	273.71	161.13
Other Income	3.52	2.37	0.32
P/L Before Int., Excpt. Items & Tax	216.70	276.08	161.45
Interest	5.95	5.81	0.82
P/L Before Exceptional Items & Tax	210.75	270.27	160.63
Exceptional Items	--	--	--
P/L Before Tax	210.75	270.27	160.63
Tax	40.00	70.30	29.78
P/L After Tax from Ordinary Activities	170.75	199.97	130.85
Prior Year Adjustments	--	--	--
Extra Ordinary Items	--	--	--
Net Profit/(Loss) For the Period	170.75	199.97	130.85
Minority Interest	0.77	-0.02	0.01
Share Of P/L Of Associates	-1.69	0.12	-0.26
Net P/L After M.I & Associates	169.83	200.07	130.60
Equity Share Capital	37.70	37.70	37.70
Reserves Excluding Revaluation Reserves	--	--	--
Equity Dividend Rate (%)	--	--	--
EPS Before Extra Ordinary
Basic EPS	9.01	10.61	6.93
Diluted EPS	9.01	10.61	6.93
EPS After Extra Ordinary
Basic EPS	9.01	10.61	6.93
Diluted EPS	9.01	10.61	6.93
Public Share Holding
No Of Shares (Crores)	--	--	--
Share Holding (%)	--	--	--
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)	--	--	--
- Per. of shares (as a % of the total sh. of prom. and promoter group)	--	--	--
- Per. of shares (as a % of the total Share Cap. of the company)	--	--	--
b) Non-encumbered
- Number of shares (Crores)	--	--	--
- Per. of shares (as a % of the total sh. of prom. and promoter group)	--	--	--
- Per. of shares (as a % of the total Share Cap. of the company)	--	--	--
Source : Dion Global Solutions Limited